ArticleThe Pan African medical journal2021
[Metabolic hepatic steatosis associated with obesity in adults living in Burkina Faso].
Article in The Pan African medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence of Liver Steatosis Among Workers in Ouagadougou and Associated Factors: A Cross-Sectional Study.JGH open : an open access journal of gastroenterology and hepatology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionis metabolic steatopathy a public health priority in Africa? The purpose of this study was to investigate the epidemiological factors and manifestations of liver involvement (biological abnormalities and steatosis on ultrasound) associated with metabolic syndrome (MS) in adults followed up on an ambulatory basis.
methodswe conducted a cross-sectional and multicenter study based on longitudinal follow-up of patients in the city of Ouagadougou from March 2015 to August 2019. All patients with MS according to Harmonized Guidelines™ for sub-Saharan Africa were enrolled.
resultsMS rate was 15.74%. Recruitment of patients was 3.8 times faster in the last year. The majority of patients were women (57.04); the average age of patients was 44.69 years. Overweight and obesity accounted for 87.32%. MS components included: dyslipidemia (64.79%), hyperglycemia (49.30%), PAH (45.07%), mean waist size (men: 98.68 cm; women: 101.13 cm). B virus infection was associated with MS in 19.01% of cases and HIV was associated with MS in 1.40% of cases. One female patient had polycystic ovary syndrome (PCOS). Patients on traditional therapy accounted for 14.08%. Transaminase levels were normal in 73.94% of cases. Hepatic steatosis on ultrasound were found in 71.13% of cases. Fibroscan® was performed in 40-42% cases. Fibroscan® results were discordant with ultrasound results in 56.14% of cases.
conclusionthis study highlights the importance of fighting against obesity (in particular obesity in women) in reducing MS and its components. A better accessibility to Fibroscan® could improve management of patients in Burkina Faso.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.